Tran Trung T TT

Show results for

Unknown (6)
Proteomics (2)

Organisms

Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Botrytis cinerea (2)
Candida albicans (2)
Clostridium perfringens (2)
Cnidaria (2)
Eukaryota (2)
Fasciola (2)
Fungi (2)
Hepatitis B virus (2)
Human betaherpesvirus 5 (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Panicum virgatum (2)
Platyhelminthes (2)
Saccharomyces cerevisiae (2)
Salmonella enterica subsp. enterica (2)
Schizosaccharomyces pombe (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Shigella (2)
Staphylococcus aureus (2)
Streptococcus pneumoniae (2)
Toxoplasma gondii (2)
Tripsacum dactyloides (2)
Trypanosoma cruzi (2)

Repository

pride (2)

Tissue

T cell (1)

Technology Type

Mass Spectrometry (2)
Immunopeptidomics (1)
SRM/MRM (1)
Shotgun proteomics (1)

Publication Date

2025 (1)
2017 (1)

Release Date

2025 (3)
2024 (1)
2023 (1)
2013 (1)

Lab affiliation

Head, Dept of Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Ullernchausséen 70, 0379 Oslo, Norway (1)
Proteomics Lab Department of Bioscience Faculty of Mathematic and Natural Science University of Oslo Norway (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells

Reversible protein phosphorylation is one of the most important posttranslational modifications (PTMs) due to its vital role in cellular functions and signaling pathways. Protein phosphorylation is also known to be involved in the regulation of apoptosis. Previously, we have performed a SILAC-based ...

ORGANISM(S): Homo sapiens (Human)

2017-05-11 | PXD004415 | Pride

TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors in vivo

CTNNB1/ ꞵ-catenin is mutated in 3.3% of solid cancers, with several recurrent gain-of-function mutations occurring early during cancer formation. This includes the shared driver mutation CTNNB1S37F, estimated to occur in >7000 new cancer cases in 2024 in the US. However, to offer attractive immunoth...

ORGANISM(S): Homo sapiens (Human)

2025-07-15 | PXD054276 | Pride

Β-catenin In vivo T cells Immunotherapy

Assessment of Common Oral Behaviors in Patients with Temporomandibular Joint Disorders and Their Relationship to Psychosocial Factors.

Not available

S-EPMC12564427 | biostudies-literature

Prevalence and determinants of faecal carriage of carbapenem- and third-generation cephalosporin-resistant Enterobacterales: a cross-sectional household survey in northern Vietnam.

Not available

S-EPMC11780954 | biostudies-literature

Prevalence and determinants of nasal carriage of penicillin non-susceptible <i>Streptococcus pneumoniae</i>: a cross-sectional household survey in northern Vietnam.

Not available

S-EPMC11764309 | biostudies-literature